Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

LABCORP HOLDINGS INC. Director's Dealing 2021

Mar 29, 2021

30237_dirs_2021-03-29_919fff67-2c44-4156-b700-5b788bb4194d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LABORATORY CORP OF AMERICA HOLDINGS (LH)
CIK: 0000920148
Period of Report: 2021-03-25

Reporting Person: Wengel Kathryn E (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-03-25 Restricted Stock Unit $ A 603 Acquired Common Stock (603) Direct

Footnotes

F1: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.

F2: The Restricted Stock Units vest fully on 3/25/2022.